glp-1 and bowel obstruction Can Glucagon-like peptide-1 (GLP-1) receptor agonists cause intestinal obstruction? Food-induced small bowel obstruction observed

Theranostics 2022;12:2741-57.ArticlePubMedPMC 88

The observation that the insulinotropic actions of GLP-1 are reduced in type 2 diabetes mellitus (T2DM) led to the development of incretin-based therapies GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of hyperglycaemia in these patients

A proprietary blend of lemon flavonoids

Manne-Goehler, J., Teufel, F

These findings suggest a potential protective role for GLP-1 signaling in modulating orbital inflammation, though prospective trials are required for confirmation

5, with the cost of the starting 1.5-mg dose set at $149 per monthor about $5 per dayfor cash-paying patients